Showing results for: "drug" (28 results)
Tuberculosis (TB) remains one of the world's deadliest infectious diseases, claiming over a million lives each year. TB is the deadliest infectious disease known today, claiming more lives than COVID-19. TB is caused by the bacterium Mycobacterium tuberculosis. TB spreads through the air when infected people breathe, cough, sneeze,
Natural polysaccharides like locust bean gum and chitosan are replacing lactose as safer, more effective carriers for inhaled medications and vaccines.
Why is mucus the biggest obstacle to lung drug delivery? Explore the mucosal barrier science reshaping how we design inhaled medicines and vaccines.
Discover how antigen-presenting cells like dendritic cells and macrophages are being recruited through smart particle design for vaccines and immunotherapy.
(DCTs) are redefining how pharmaceutical studies are designed, conducted, and analyzed by moving away from traditional site-centric models toward patient-centric, digitally enabled trial ecosystems.
Animal models have traditionally served as the cornerstone of drug safety evaluation; however, major translational challenges persist due to interspecies differences in physiology, metabolism, and genetic regulation. Many compounds demonstrating favorable toxicity profiles in animals later fail during human trials or are withdrawn post-marketing due to unforeseen adverse effects, especially hepatotoxicity and cardiotoxicity (Lee et al., 2025).
Vancomycin is an essential glycopeptide antibiotic used to treat life-threatening infections caused by Gram-positive bacteria, particularly Methicillin-Resistant Staphylococcus aureus (MRSA). It functions by inhibiting bacterial cell-wall synthesis and is still the most potent drug to be used when others fail (Patel, Preuss, & Bernice, 2023).
From innovative methods for cancer treatment to understanding the complexities of the human gut biome, these discoveries not only enhance our comprehension of the world but also lay the foundation for future groundbreaking advancements.
Nanotechnology is having a big impact on pharmaceutical sciences, and drug delivery systems are one area where this is most evident. Compared to conventional medication delivery methods, nanoparticles provide a number of benefits, including increased effectiveness and fewer adverse drug reactions.
Healthcare is changing faster than ever before. Thanks to breakthroughs in artificial intelligence (AI), genomics, and wearable technology, medicine is entering the era of smart health, where data, devices, and biology work together to create care tailored to the individual.
Modern healthcare is undergoing a silent revolution. Now to treat a disease in the healthcare system, there is no longer a need to wait for symptoms to appear.
Inhaled antibiotics deliver drugs directly to lung infections, achieving better results with fewer side effects, which is a game-changer in fighting resistance.
Today, generalized anxiety disorder is affecting millions of Americans. The disorder usually traps the sufferers in cycles of fear and isolation in a way that even standard treatments cannot relieve completely. UCSF neuroscientist Jennifer Mitchell, PhD, is testing a surprising brand-new approach that can ease symptoms of generalized anxiety disorder by reshaping how the brain thinks and feels.
Stem cell therapy research is a promising area of interest for a number of scientists working to understand Parkinson’s disease and develop treatments for it. Read below to learn more about the advancements of stem cell therapy for Parkinson’s.
Traditionally, Forensic Science relies on Human DNA for contact evidence and individual identification, but limitation arises when the blood cells obtained from the crime scene are degraded or not.
This article aims to demystify the anatomy of a clinical trial protocol, peeling back the technical layers to reveal how scientific rigor is converted into medical progress. At ScientistsHub, we often ask: How do we ensure that a medical breakthrough is not just a stroke of luck, but a repeatable, verifiable victory for human health? The answer is found in the design. To truly appreciate the result of any trial, one must first master the architecture of the inquiry.
This architecture is essential for shielding neurons from toxins, pathogens, and fluctuations in the bloodstream, but it also creates a devastating bottleneck for modern medicine. More than 98% of small-molecule drugs and nearly all large biological therapeutics fail to cross the BBB in meaningful amounts, leaving many promising treatments for neurodegenerative disorders, brain tumors, and inflammatory diseases stranded in the circulation.
Cell and gene therapies represent a seismic shift in healthcare. They promise to cure the incurable, restoring sight to the blind and erasing cancer from the blood. But this frontier is wild. It comes with biological price tags, potential genetic misfires, and a regulatory landscape that is still being mapped.
Selective oxidation reactions are central to modern biochemistry. They enable the controlled introduction of oxygen into organic molecules, a key step in the synthesis of pharmaceuticals and fine chemicals. However, many of the enzymatic systems traditionally used for these transformations are complex and difficult to implement in practice.
A future without transplant waitlists? Tissue engineering blends biology and engineering to build living, functional human tissue.
